Management of Posterior Fossa Cerebellar Subarachnoid Hemorrhage

Blood Pressure Management

Patients with SAH require close blood pressure monitoring due to competing risks, with blood pressure targets changing dramatically between pre-aneurysm securing and post-securing phases, often requiring induced hypertension with MAP >90 mmHg 1
Rapid BP fluctuations are associated with increased rebleeding risk and should be avoided, but may occur spontaneously due to autonomic instability 1

Cerebral vasospasm occurs frequently in SAH patients and is associated with delayed cerebral ischemia (DCI), affecting approximately 30% of patients between days 4-14 after SAH 2
Impaired cerebral autoregulation in SAH leads to variable readings in transcranial Doppler (TCD) and other monitoring parameters, with readings changing based on the patient's level of consciousness 3
Vasospasm can cause variable flow velocities in cerebral vessels, with the middle cerebral artery showing greater sensitivity to detection than other vessels 4

Arterial line monitoring is strongly recommended over non-invasive cuff monitoring for blood pressure management in SAH patients due to the need for precise, continuous monitoring 1
Transcranial Doppler (TCD) readings may show variable results in detecting vasospasm, with TCCD (transcranial color-coded duplex) showing higher sensitivity than conventional TCD 4
Continuous EEG monitoring may show variable readings with decreasing relative alpha power variability, decreasing alpha-to-delta power ratio, worsening focal slowing, or late-appearing epileptiform abnormalities that predict DCI 2

Spontaneous hyperventilation (PaCO2 < 35 mm Hg and pH > 7.45) occurs in SAH and is associated with DCI and poor neurological outcome 3
Changes in carbon dioxide levels can alter cerebral blood flow by widening the plateau on the autoregulatory curve, causing variable readings in cerebral perfusion parameters 3
Invasive neuromonitoring techniques like partial pressure of brain tissue oxygen (PbtO2) and cerebral microdialysis may show variable readings in lactate/pyruvate ratio and glutamate concentrations that correlate with DCI 2
Hemoglobin levels in SAH patients may fluctuate and affect monitoring parameters, with some studies suggesting higher nadir and mean Hb levels (>10 g/dL) are associated with better outcomes 5
Transfusion thresholds vary from 7-9 g/dL historically, but some studies suggest maintaining Hb >10 g/dL may be beneficial, with thresholds of 10.4 g/dL and 10.9 g/dL identified as cutoffs for predicting vasospasm and brain infarction 5